Pricing Log in Create free account
Saturday 17 October 2026 Export ABT’s income statement to Excel — free account

Abbott Laboratories

ABT Healthcare Medical Devices

Abbott Laboratories' revenue for fiscal 2025 (year ended December 2025) was $44.3 billion, up 5.67% from fiscal 2024. In the quarter to June 2026, revenue grew 13.0%, EPS fell 47.5%, free cash flow grew 28.9% and total debt rose 142.7%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years; insiders bought in the last twelve months.

104.88 0.20 +0.19%
Market cap
$181.1B
P/E
33.9×
Fwd P/E
22.9×
Dividend yield
2.40%
F-score
5/9
Altman Z
5.61
Beneish M
−2.50
Dividend safety
62/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Abbott Laboratories (ABT) Free cash flow

Alert me on Free cash flow

Abbott Laboratories's free cash flow for fiscal 2025 was $7.4B, up 16.4% from $6.4B in fiscal 2024. Over the twelve months to 30 June 2026 it was $7.8B. Over the past ten years it has ranged from $1.9B (fiscal 2015) to $8.6B (fiscal 2021); the current reading is higher than 82% of that period. Abbott Laboratories ranks 1st of 149 Medical Devices companies by free cash flow.

Free cash flow, annual

Embed this chart

Annual newest first

Period Free cash flow Change
FY2025 $7.4B 16.44%
FY2024 $6.4B 25.54%
FY2023 $5.1B (35.17%)
FY2022 $7.8B (9.76%)
FY2021 $8.6B 51.08%
FY2020 $5.7B 27.26%
FY2019 $4.5B (8.32%)
FY2018 $4.9B 10.62%
FY2017 $4.4B 113.02%
FY2016 $2.1B 12.18%

Quarterly newest first

Period Free cash flow Change
Jun 2026 $2.0B 117.36%
Mar 2026 $916.0M (65.12%)
Dec 2025 $2.6B 14.62%
Sep 2025 $2.3B 48.28%
42 more quarters

Against its own ten years

Low $1.9B High $8.6B
Ten-year median $5.1B
Current reading's percentile 82

Free cash flow against peers

Company Free cash flow
ABT Abbott Laboratories $7.8B
MDT Medtronic PLC compare $6.1B
SYK Stryker Corporation compare $4.7B
BSX Boston Scientific Corporation compare $3.6B
PHG Koninklijke Philips N.V. compare $1.8B
GEHC GE HealthCare Technologies Inc. compare $1.6B
EW Edwards Lifesciences Corporation compare $1.4B
DXCM DexCom, Inc. compare $1.4B
STE STERIS plc compare $936.0M

What Free cash flow is

Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.

Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)

The full definition of Free cash flow →

More on ABT